Analyst Ratings for Aeglea Biotherapeutics (AGLE) [Buys]
AGLE Rating Summary
AGLE Price Target Summary
- Highest: $23.00 (Stifel)
- Lowest: $12.00 (Wells Fargo)
- Average: $17.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$17.50 (+45.7%)
* Over Last 12-Mos
Rating Score: 5.5 / 10
Percentile Rank: 59%
Avg. $ Target:
$17.50 (+45.7%)
* Over Last 12-Mos
Rating Score: 5.5 / 10
Percentile Rank: 59%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/25/2023 | Stifel » Updated 10/23/2023 |
Alex Thompson | New Coverage | Buy (N/A) |
23.00 (N/A) |
0.59 (12.01) |
1935.59% | Details |
| 10/27/2022 | Piper Sandler | Edward A. Tenthoff | Upgrade | Overweight (Neutral) |
1.50 (1.00) |
0.50 (12.01) |
2302% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
